SCHEMBL3986428

SCHEMBL3986428

O=C(C=Cc1ccc(O)c(O)c1)OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.65
▸ TDP1 Q9NUW8 1/20 0.65
▸ PRKCA P17252 7/20 0.64
▸ HSP90AA1 P07900 1/20 0.59
▸ CYP19A1 P11511 2/20 0.58
▸ ALDH1A1 P00352 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ ALOX15 P16050 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ KDM1A O60341 2/20 0.56
▸ BACE1 P56817 1/20 0.56
▸ SNCA P37840 1/20 0.54
▸ AKR1B1 P15121 1/20 0.53
▸ DPP4 P27487 1/20 0.53
▸ CYP46A1 Q9Y6A2 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL546757 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL31487400 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL30669730 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL15711523 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL15147273 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL2333086 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL15144478 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL29531507 1.00 GAA (0.65) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL9234208 0.90 SNCA (0.54) GAATDP1PRKCAHSP90AA1CYP19A1
SCHEMBL9231411 0.90 SNCA (0.54) GAATDP1PRKCAHSP90AA1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116077548-A Compositions and methods for treating lower urinary tract symptoms, benign prostatic hypertrophy, and erectile dysfunction 奇华顿股份有限公司 2023-05-09 — — CN claimed
CN-115925760-A Caffeoyl glucoside compounds extracted from Hypericum virgatum, and extraction method and application thereof 湖南省粤宁康生物科技有限公司 2023-04-07 — — CN claimed
US-20220175863-A1 COMPOSITIONS AND METHODS USEFUL IN TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION, AND OTHER DISEASES OR SYMPTOMS NATUREX INC. 2022-06-09 — — US claimed
CN-110133141-B Method for identifying camellia flower color bud mutation variety 中国林业科学研究院亚热带林业研究所 2022-05-27 — — CN claimed
US-11291703-B2 Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms NATUREX INC. (US) 2022-04-05 — — US claimed
US-11045511-B2 Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms NATUREX INC. (US) 2021-06-29 — — US claimed
US-10898534-B2 Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms NATUREX INC. (US) 2021-01-26 — — US claimed
US-20200121750-A1 Compositions and Methods Useful in Treatment of Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, Erectile Dysfunction and Other Diseases or Symptoms Naturex-DBS, LLC 2020-04-23 — — US claimed
US-20180256663-A1 COMPOSITIONS AND METHODS USEFUL IN TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND OTHER DISEASES OR SYMPTOMS NATUREX INC. 2018-09-13 — — US claimed
US-20160324911-A1 COMPOSITIONS AND METHODS USEFUL IN TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION Naturex-DBS, LLC 2016-11-10 — — US claimed
EP-3068414-A1 COMPOSITIONS AND METHODS USEFUL IN TREATMENT OF LOWER URINARY TRACT SYSPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION Naturex-DBS LLC (US) 2016-09-21 — — EP claimed
WO-2015070203-A1 COMPOSITIONS AND METHODS USEFUL IN TREATMENT OF LOWER URINARY TRACT SYSPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION NATUREX-DBS LLC (US) 2015-05-14 — — WO claimed
CN-119060967-A Enzyme product and method for synthesizing chlorogenic acid 河北省科学院生物研究所 2024-12-03 — — CN disclosed
CN-118235824-A Drink composition prepared from sakura and plant extracts and preparation method of drink composition 溱湖原子生物科技(江苏)有限公司 2024-06-25 — — CN disclosed
US-20240191273-A1 ANTHOCYANIN BIOPRODUCTION IN A CELL-FREE MANUFACTURING SYSTEM Debut Biotechnology, Inc. 2024-06-13 — — US disclosed
US-12005095-B2 Eutectic extraction solvents, extraction methods by eutectigenesis using said solvents, and extracts derived from said extraction methods GIVAUDAN FRANCE NATURALS SAS (FR) 2024-06-11 — — US disclosed
EP-1848443-A2 COMPOUNDS USEFUL FOR TREATING HIV Millenia Hope Pharmaceuticals Inc. (CA) 2007-10-31 — — EP disclosed
CN-101052719-A Method for stabilizing and bluing anthocyanin pigment using gene encoding anthocyanin 3' -position aromatic acyltransferase INTERNAT FLOWER DEV PTY LTD (AU) 2007-10-10 — — CN disclosed
WO-2006088824-A2 COMPOUNDS USEFUL FOR TREATING HIV MILLENIA HOPE PHARMACEUTICALS INC. (CA) 2006-08-24 — — WO disclosed
WO-1997041137-A1 USE OF ANTHOCYANIDIN AND ANTHOCYANIDIN DERIVATIVES UNIFOB (NO) 1997-11-06 — — WO disclosed
Send feedback